M Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck’s core business areas. Operating since 2009, M Ventures invests globally in early-stage companies that are developing pioneering science and technology, focusing on four main fields: Healthcare, Life Science, Performance Materials, and other strategic areas such as Bio-sensing & Interfaces and Liquid Biopsy Technologies.

Founded in

South Korea